The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 03 2020
revised: 26 05 2020
accepted: 28 05 2020
pubmed: 17 6 2020
medline: 27 1 2022
entrez: 17 6 2020
Statut: ppublish

Résumé

To determine if obtaining a 24-hour urine collection (24HU) in stone formers is associated with decreased recurrent stone episodes. Using the MarketScan database, adults 17-62 years old with nephrolithiasis were identified between 2007 and 2017 with a minimum of 3-year follow up. High-risk stone formers, those undergoing stone surgery, and those with history of recurrent stones were identified. The exposure was a 24HU within 6 months of primary diagnosis. The outcome was recurrent stone episodes-defined by stone-related emergency room visits, hospitalizations, or stone surgery 90 days to 3 years after diagnosis. Logistic regression was used to estimate recurrence risk by 24HU exposure for the overall cohort and sub-cohorts limited to known recurrent stone formers, high-risk subjects, and those having stone surgery. Of 434,055 subjects analyzed, 30,153 (6.9%) had a 24HU. An annual decline in 24HU utilization was seen (7.5%-5.8%). Regional variation in usage rate was also observed. On multivariate analysis, completing a 24HU was not associated with risk of recurrence in any of the following cohorts: recurrent stone formers (OR 0.98, 95% CI 0.9-1.07), both high risk and recurrent stone formers (OR 0.95 [0.8-1.13]), those undergoing surgery (OR 1.02 [0.97-1.07]); a positive association with 24HU and recurrence was seen in those labeled high-risk (OR 1.08 [1.01-1.16]) and in all-comers (OR 1.15 [1.12-1.19]). The 24HU was not associated with decreased recurrence rates in the overall population nor in higher risk sub-cohorts.

Identifiants

pubmed: 32540303
pii: S0090-4295(20)30671-3
doi: 10.1016/j.urology.2020.05.064
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-76

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Patrick C Samson (PC)

Department of Urology, Weill Cornell Medicine, New York, NY. Electronic address: psams13@gmail.com.

Sarah K Holt (SK)

Department of Urology, University of Washington Medical Center, Seattle, WA.

Ryan S Hsi (RS)

Department of Urology, Vanderbilt University Medical Center, Nashville, TN.

Mathew D Sorensen (MD)

Department of Urology, University of Washington Medical Center, Seattle, WA; Division of Urology, Veterans Affairs Medical Center, Seattle, WA.

Jonathan D Harper (JD)

Department of Urology, University of Washington Medical Center, Seattle, WA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH